ABC
ENTA icon

Associated Banc-Corp’s Enanta Pharmaceuticals ENTA Stock Holding History

Associated Banc-Corp’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27
Closed -$1K – 1012
2020
Q2 		$1K Buy
+27
New +$1.4K ﹤0.01% 851

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Associated Banc-Corp's ENTA Position: Q3 2020 in Review

Associated Banc-Corp sold out of Enanta Pharmaceuticals (ENTA) in Q3 2020, closing a stake of 27 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in ENTA in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 172 funds tracked by Wall St. Rank hold ENTA as of Q3 2020.

  • Associated Banc-Corp reported no remaining Enanta Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 27 Enanta Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Associated Banc-Corp first reported a position in Enanta Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Associated Banc-Corp's Enanta Pharmaceuticals position peaked at $1K in Q2 2020.
  • 172 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2020.

Based on Associated Banc-Corp's 13F filing for Q3 2020, filed 12 Nov 2020.